Midazolam dose correlates with abnormal hippocampal growth and neurodevelopmental outcome in preterm infants

Abstract

Midazolam exposure was associated with macro- and microstructural alterations in hippocampal development and poorer outcomes consistent with hippocampal dysmaturation. Use of midazolam in preterm neonates, particularly those not undergoing surgery, is cautioned.